Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 20 | 2023 | 39 | 3.580 |
Why?
|
| Anaphylaxis | 4 | 2023 | 10 | 1.780 |
Why?
|
| Asthma | 7 | 2023 | 83 | 0.800 |
Why?
|
| Immunity, Innate | 2 | 2015 | 53 | 0.760 |
Why?
|
| Epinephrine | 3 | 2023 | 28 | 0.690 |
Why?
|
| Child | 13 | 2023 | 990 | 0.600 |
Why?
|
| Irritable Bowel Syndrome | 2 | 2008 | 8 | 0.580 |
Why?
|
| Sinusitis | 5 | 2018 | 159 | 0.580 |
Why?
|
| Surveys and Questionnaires | 7 | 2023 | 977 | 0.510 |
Why?
|
| Child Day Care Centers | 2 | 2006 | 3 | 0.500 |
Why?
|
| Caregivers | 3 | 2023 | 168 | 0.500 |
Why?
|
| Desensitization, Immunologic | 1 | 2015 | 3 | 0.480 |
Why?
|
| Rhinitis, Allergic | 3 | 2023 | 15 | 0.470 |
Why?
|
| Rhinitis | 4 | 2018 | 142 | 0.460 |
Why?
|
| Renal Dialysis | 1 | 2015 | 67 | 0.460 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 102 | 0.450 |
Why?
|
| Humans | 34 | 2023 | 22848 | 0.410 |
Why?
|
| Dermatitis, Atopic | 3 | 2018 | 13 | 0.370 |
Why?
|
| Mast Cells | 2 | 2008 | 17 | 0.360 |
Why?
|
| Allergens | 4 | 2023 | 13 | 0.350 |
Why?
|
| Adolescent | 7 | 2023 | 1775 | 0.310 |
Why?
|
| Gastroesophageal Reflux | 2 | 2021 | 26 | 0.310 |
Why?
|
| Child, Preschool | 7 | 2021 | 489 | 0.280 |
Why?
|
| Hypersensitivity | 1 | 2008 | 34 | 0.280 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 139 | 0.280 |
Why?
|
| Female | 19 | 2022 | 12677 | 0.260 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2018 | 133 | 0.250 |
Why?
|
| Infant | 6 | 2021 | 449 | 0.240 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2004 | 8 | 0.230 |
Why?
|
| Peroxidase | 1 | 2004 | 15 | 0.230 |
Why?
|
| Vasculitis | 1 | 2004 | 24 | 0.230 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2014 | 39 | 0.230 |
Why?
|
| Infant, Premature, Diseases | 1 | 2004 | 25 | 0.220 |
Why?
|
| Lung Diseases | 1 | 2004 | 38 | 0.220 |
Why?
|
| Hemorrhage | 1 | 2004 | 73 | 0.220 |
Why?
|
| Kidney Diseases | 1 | 2004 | 66 | 0.220 |
Why?
|
| Adult | 11 | 2018 | 6584 | 0.210 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2023 | 2 | 0.210 |
Why?
|
| Male | 17 | 2022 | 12453 | 0.200 |
Why?
|
| Shellfish Hypersensitivity | 1 | 2022 | 1 | 0.200 |
Why?
|
| Cockroaches | 1 | 2022 | 1 | 0.200 |
Why?
|
| Celiac Disease | 1 | 2002 | 5 | 0.190 |
Why?
|
| Digestive System | 1 | 2002 | 12 | 0.190 |
Why?
|
| Pancreatitis | 1 | 2002 | 17 | 0.190 |
Why?
|
| Quality of Life | 2 | 2023 | 504 | 0.190 |
Why?
|
| Crohn Disease | 1 | 2002 | 36 | 0.190 |
Why?
|
| Prospective Studies | 5 | 2023 | 1528 | 0.180 |
Why?
|
| Diet | 2 | 2021 | 199 | 0.180 |
Why?
|
| Bullying | 1 | 2020 | 3 | 0.180 |
Why?
|
| Microbiota | 2 | 2018 | 85 | 0.170 |
Why?
|
| Chronic Disease | 6 | 2018 | 361 | 0.170 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2013 | 6 | 0.160 |
Why?
|
| Mastocytosis | 1 | 2019 | 1 | 0.160 |
Why?
|
| Intestinal Mucosa | 2 | 2014 | 144 | 0.160 |
Why?
|
| Poverty | 1 | 2020 | 79 | 0.160 |
Why?
|
| Parents | 1 | 2020 | 86 | 0.160 |
Why?
|
| Physicians | 1 | 2020 | 103 | 0.150 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2008 | 4 | 0.150 |
Why?
|
| Prevalence | 4 | 2023 | 377 | 0.140 |
Why?
|
| Nose | 1 | 2018 | 36 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 26 | 0.140 |
Why?
|
| Pollen | 1 | 2016 | 2 | 0.130 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2016 | 3 | 0.130 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 57 | 0.130 |
Why?
|
| Minority Groups | 1 | 2016 | 64 | 0.130 |
Why?
|
| Middle Aged | 9 | 2018 | 7555 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 67 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 76 | 0.120 |
Why?
|
| Skin Tests | 1 | 2015 | 6 | 0.120 |
Why?
|
| Nasal Polyps | 1 | 2016 | 53 | 0.120 |
Why?
|
| Granulocytes | 1 | 2014 | 11 | 0.110 |
Why?
|
| United States | 4 | 2021 | 1726 | 0.110 |
Why?
|
| Toll-Like Receptors | 1 | 2014 | 15 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2014 | 63 | 0.110 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 7 | 0.110 |
Why?
|
| Hospitalization | 1 | 2016 | 272 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 40 | 0.100 |
Why?
|
| Infant, Newborn | 3 | 2016 | 509 | 0.100 |
Why?
|
| Odds Ratio | 2 | 2016 | 241 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2022 | 1621 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 187 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 155 | 0.100 |
Why?
|
| Receptors, IgE | 1 | 2009 | 1 | 0.080 |
Why?
|
| Immunoglobulin E | 1 | 2009 | 8 | 0.080 |
Why?
|
| Pregnancy | 2 | 2013 | 303 | 0.080 |
Why?
|
| Neutrophils | 1 | 2009 | 85 | 0.080 |
Why?
|
| Aged | 5 | 2016 | 7669 | 0.080 |
Why?
|
| South Africa | 2 | 2018 | 11 | 0.070 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2008 | 3 | 0.070 |
Why?
|
| Risk Factors | 2 | 2017 | 1942 | 0.070 |
Why?
|
| Cytokines | 1 | 2008 | 167 | 0.070 |
Why?
|
| Health Education | 1 | 2006 | 41 | 0.060 |
Why?
|
| Data Collection | 1 | 2006 | 73 | 0.060 |
Why?
|
| Enterocolitis | 1 | 2006 | 3 | 0.060 |
Why?
|
| Mastocytosis, Systemic | 1 | 2006 | 5 | 0.060 |
Why?
|
| Diarrhea | 1 | 2006 | 26 | 0.060 |
Why?
|
| Illinois | 2 | 2017 | 211 | 0.060 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 6 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2004 | 15 | 0.060 |
Why?
|
| Blood Transfusion | 1 | 2004 | 61 | 0.060 |
Why?
|
| Young Adult | 3 | 2018 | 1721 | 0.060 |
Why?
|
| Depression | 1 | 2008 | 375 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 90 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2016 | 3062 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2004 | 175 | 0.050 |
Why?
|
| Pyroglyphidae | 1 | 2022 | 1 | 0.050 |
Why?
|
| Dermatophagoides pteronyssinus | 1 | 2022 | 1 | 0.050 |
Why?
|
| Dust | 1 | 2022 | 2 | 0.050 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2022 | 2 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 685 | 0.050 |
Why?
|
| Gastric Acid | 1 | 2002 | 8 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2022 | 35 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 89 | 0.050 |
Why?
|
| Permeability | 1 | 2002 | 87 | 0.050 |
Why?
|
| Acute Disease | 1 | 2002 | 147 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2002 | 30 | 0.050 |
Why?
|
| Shellfish | 1 | 2021 | 2 | 0.040 |
Why?
|
| Schools | 1 | 2020 | 43 | 0.040 |
Why?
|
| Food | 1 | 2020 | 33 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 320 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 82 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 4055 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 713 | 0.040 |
Why?
|
| Biodiversity | 1 | 2018 | 12 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 59 | 0.040 |
Why?
|
| Syndrome | 1 | 2016 | 60 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 334 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 62 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2016 | 103 | 0.030 |
Why?
|
| Animals | 1 | 2022 | 3025 | 0.030 |
Why?
|
| Aspirin | 1 | 2016 | 70 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 254 | 0.030 |
Why?
|
| Exhalation | 1 | 2014 | 2 | 0.030 |
Why?
|
| Spirometry | 1 | 2014 | 8 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2014 | 53 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2014 | 22 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 55 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 218 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2013 | 11 | 0.030 |
Why?
|
| Vincristine | 1 | 2013 | 20 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2013 | 37 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2013 | 32 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2013 | 35 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 26 | 0.030 |
Why?
|
| Rituximab | 1 | 2013 | 40 | 0.030 |
Why?
|
| Prednisone | 1 | 2013 | 61 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 215 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 500 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2014 | 400 | 0.020 |
Why?
|
| Basophils | 1 | 2009 | 4 | 0.020 |
Why?
|
| Superoxides | 1 | 2009 | 13 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 130 | 0.020 |
Why?
|
| Ranitidine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Cetirizine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2006 | 2 | 0.020 |
Why?
|
| Tryptases | 1 | 2006 | 4 | 0.020 |
Why?
|
| Duodenum | 1 | 2006 | 4 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 60 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 127 | 0.020 |
Why?
|
| Colon | 1 | 2006 | 104 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 2960 | 0.010 |
Why?
|